ROZLYTREK (entrectinib) capsules is used for the treatment of patients with non-small cell lung cancer Treatment. Entrectinib (INN, trade name Rozlytrek previously known as RXDX-101 and NMS-E628) is an anti-cancer drug used to treat ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors. It was approved in the United States on 15 August 2019. It is a selective tyrosine kinase inhibitor (TKI), of the tropomyosin receptor kinases (Trk) A, B and C, C-ros oncogene 1 (ROS1) and anaplastic lymphoma kinase (ALK).<\/p>\n
ROZLYTREK (entrectinib) capsules is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed. If ROZLYTREK (entrectinib) capsules are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN.<\/strong>\u00a0For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query.\u00a0Like 1. How to get access in in India. 2. Medicine Price. 3. Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia. 4. Ensuring 100% transparency.\u00a0<\/strong><\/p>\n ROZLYTREK (entrectinib) capsules can be made available to patients, doctors, and hospitals in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.<\/p>\n To receive comprehensive support, please call us at\u00a09811747774<\/a>,\u00a09891296838<\/a>\u00a0or WhatsApp at\u00a09811747774<\/a>,\u00a09891296838\u00a0<\/a>or email us at\u00a0info@indianpharmanetwork.co.in\u00a0<\/a> for ROZLYTREK (entrectinib) capsules in India.<\/strong><\/p>\n NEWS \/ UPDATES<\/strong><\/p>\n Note:<\/strong><\/em> ROZLYTREK is a kinase inhibitor indicated for the treatment of:\u00a0\u2022 Adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive.\u00a0\u2022 Adult and pediatric patients 12 years of age and older with solid tumors.<\/p>\n Source Details:\u00a0Patient Information<\/strong><\/a><\/p>\n\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.\u00a0Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a>. With over two decades of industry experience, IPN offers extensive coverage across India.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"Brand Name: ROZLYTREK Generic Name: entrectinib. It is used to treat non-small cell lung cancer (NSCLC).<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n ROZLYTREK<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n entrectinib<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n \u2022 Capsules: 100 mg and 200 mg<\/td>\n<\/tr>\n \n Manufacturer:<\/strong><\/td>\n Genentech<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Access the best support services globally<\/h4>\n